# Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025
Canonical URL: https://biopharmsignal.com/news/ASRT/assertio-to-participate-in-the-hc-wainwright-and-lake-street-conferences-in-sept-8cca2126
Ticker: ASRT
Company: Assertio
Source: Assertio
Published: 2025-09-03 12:15 EST
## Summary

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its...

## Article Body
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during September 2025.

Company management will host investor meetings at the HC Wainwright Conference on Wednesday, September 10, 2025, taking place at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative.

The Company will also participate in investor meetings at the Lake Street Capital Markets BIG9 Conference, taking place September 11, 2025 at the Yale Club New York City. Investors can register and request meetings through their Lake Street representative.

About Assertio

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com .

Investor Contact

Matt Kreps, Managing Director Darrow Associates M: 214-597-8200 mkreps@darrowir.com
## Recent Company News
- 2025-10-28 13:15 EST — [Assertio Announces Leadership Transition](https://biopharmsignal.com/news/ASRT/assertio-announces-leadership-transition-13208d9d) — Source: Assertio
- 2025-09-15 13:00 EST — [Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV](https://biopharmsignal.com/news/ASRT/assertio-presents-first-ever-real-world-study-showing-patient-experience-with-sy-14523696) — Source: Assertio
- 2025-09-10 11:30 EST — [Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association](https://biopharmsignal.com/news/ASRT/assertio-to-present-new-data-from-real-world-evidence-study-of-sympazan-at-upcom-a319cbba) — Source: Assertio
- 2025-09-03 12:15 EST — [Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025](https://biopharmsignal.com/news/ASRT/assertio-to-participate-in-the-hc-wainwright-and-lake-street-conferences-in-sept-8cca2126) — Source: Assertio
- 2025-08-11 20:05 EST — [Assertio Reports Second Quarter 2025 Financial Results](https://biopharmsignal.com/news/ASRT/assertio-reports-second-quarter-2025-financial-results-d87a0872) — Source: Assertio
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)